Tau accumulation and its association with neurodegeneration and cognitive impairments demonstrated in the current study were reported in several previous animal60,68,72 and in clinical studies, where total tau (t-tau) and p-tau have been recognized as essential biomarkers for AD and have undergone successful validation through controlled, large-scale, multicenter studies80. The gene discussed is MAPT; the disease is Cognitive impairment.